Burney Company’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,861
| Closed | -$1.56M | – | 591 |
|
|
2025
Q1 | $1.56M | Buy |
14,861
+1,341
| +10% | +$141K | 0.06% | 247 |
|
|
2024
Q4 | $1.45M | Buy |
13,520
+2,399
| +22% | +$257K | 0.05% | 262 |
|
|
2024
Q3 | $1.11M | Buy |
11,121
+7,650
| +220% | +$766K | 0.04% | 300 |
|
|
2024
Q2 | $292K | Sell |
3,471
-53
| -2% | -$4.47K | 0.01% | 516 |
|
|
2024
Q1 | $258K | Buy |
3,524
+416
| +13% | +$30.4K | 0.01% | 546 |
|
|
2023
Q4 | $222K | Buy |
+3,108
| New | +$222K | 0.01% | 543 |
|
|
2023
Q3 | – | Sell |
-52,030
| Closed | -$3.75M | – | 583 |
|
|
2023
Q2 | $3.75M | Buy |
+52,030
| New | +$3.75M | 0.17% | 156 |
|